Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Royal DSM N.V.    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Royal DSM N : DSM completes acquisition of Erber Group

10/02/2020 | 02:15am EST

Heerlen, NL, 02 Oct 2020 08:00 CEST

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, today announces the completion of its acquisition of Erber Group for an enterprise value of €980 million. The transaction - which excludes two smaller units in the Erber Group - is expected to be earnings enhancing in the first year upon completion. The acquisition of Erber Group was first announced on 12 June 2020.

DSM acquired Erber Group's Biomin and Romer Labs. Erber Group's specialty animal nutrition and health business Biomin specializes primarily in mycotoxin risk management and gut health performance management, whereas the Romer Labs business focuses on food and feed safety diagnostic solutions. Both expand DSM's range of higher value-add specialty solutions.

The acquisition of Erber Group's Biomin further strengthens DSM's expertise and reputation as a leading provider of animal health and nutrition solutions for farm productivity and sustainability, with an emphasis on emissions reduction, feed consumption efficiency, and better use of water and land. It is therefore very much aligned with DSM's focus to make animal farming more sustainable from both an ecological and economical perspective. Romer Labs also complements DSM's human nutrition and health offering to customers in the food & beverages market segments.

Disclaimer

Koninklijke DSM NV published this content on 02 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 October 2020 06:14:07 UTC


© Publicnow 2020
All news about ROYAL DSM N.V.
06:05aROYAL DSM N : DSM Engineering Materials improves European distribution through k..
PU
11/27ROYAL DSM N : DSM and Neste announce strategic partnership to create high perfor..
PU
11/25HUAMI CORP : and Royal DSM announce collaboration on wearable technologies and h..
AQ
11/24ROYAL DSM N : Huami Corp and Royal DSM announce collaboration on wearable techno..
PU
11/24Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations..
AQ
11/18ROYAL DSM N : DSM expands Animal Nutrition & Health operations in China with ope..
PU
11/12International companies to host live webcasts at Deutsche Bank's Depositary R..
AQ
11/09ROYAL DSM N.V. : Crossing thresholds
CO
11/03GLOBAL MARKETS LIVE: Ant Group’s IPO postponed; Deutsche Bank wants to get ri..
11/03ROYAL DSM N : DSM Q3 core profit beats as demand for materials improves
RE
More news
Financials
Sales 2020 8 435 M 10 108 M 10 108 M
Net income 2020 688 M 825 M 825 M
Net Debt 2020 2 592 M 3 106 M 3 106 M
P/E ratio 2020 36,3x
Yield 2020 1,79%
Capitalization 23 231 M 27 776 M 27 841 M
EV / Sales 2020 3,06x
EV / Sales 2021 2,80x
Nbr of Employees 21 844
Free-Float 94,7%
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 144,56 €
Last Close Price 137,00 €
Spread / Highest target 31,4%
Spread / Average Target 5,52%
Spread / Lowest Target -43,1%
EPS Revisions
Managers
NameTitle
Dimitri de Vreeze Co-Chief Executive Officer & COO
Géraldine Matchett Co-Chief Executive Officer & CFO
Robert John Routs Chairman-Supervisory Board
Pauline F. M. van der Meer Mohr Deputy Chairman
Eileen A. Kennedy Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM N.V.18.00%27 776
SHIN-ETSU CHEMICAL CO., LTD.39.68%67 645
BASF SE-9.55%66 898
DUPONT DE NEMOURS, INC.0.53%47 363
FMC CORPORATION15.88%15 009
EVONIK INDUSTRIES AG-7.61%13 981